Cross Border Comparison of MRSA Bacteraemia between The Netherlands and North Rhine-Westphalia

We describe the impact of methicillin-resistant Staphylococcus aureus (MRSA) in two neighbouring regions in Europe with a comparable population size, North Rhine-Westphalia (NRW) in Germany and the Netherlands. We compared the occurrence of MRSA in blood cultures from surveillance systems. In the Ne...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2012-08, Vol.7 (8), p.e42787
Main Authors: van Cleef, Brigitte A. G. L, Kluytmans, Jan A. J. W, van Benthem, Birgit H. B, Haenen, Anja, Monen, Jos, Daniels-Haardt, Inka, Jurke, Annette, Friedrich, Alexander W
Format: Article
Language:English
Subjects:
Blood tests
Staphylococcus aureus
Staphylococcus aureus infections
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We describe the impact of methicillin-resistant Staphylococcus aureus (MRSA) in two neighbouring regions in Europe with a comparable population size, North Rhine-Westphalia (NRW) in Germany and the Netherlands. We compared the occurrence of MRSA in blood cultures from surveillance systems. In the Netherlands in 2009, 14 of 1,510 (0.9%) Staphylococcus aureus bacteraemia episodes under surveillance were MRSA. Extrapolation using the number of clinical admissions results in a total of 29 MRSA bacteraemia episodes in the Netherlands or 1.8 episodes per 1,000,000 inhabitants. In 2010 in NRW, 1,029 MRSA bacteraemias were reported, resulting in 57.6 episodes of MRSA bacteraemia per 1,000,000 inhabitants: a 32-fold higher incidence than in the Netherlands. Based on an estimated attributable mortality of 15%, the Dutch approach would save approximately 150 lives per year by the prevention of bacteraemia only.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0042787